financetom
Business
financetom
/
Business
/
EU to cajole Trump on trade while readying tariff retaliation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU to cajole Trump on trade while readying tariff retaliation
Nov 21, 2024 8:40 AM

BRUSSELS (Reuters) - The European Union should seek constructive engagement on trade with the incoming Trump administration, but be ready to hit back in a coordinated way at the United States if it imposes new tariffs on the 27-nation bloc, EU ministers agreed on Thursday.

In the lead-up to his election victory, Donald Trump said the EU would "pay a big price" with tariffs for not buying enough U.S. exports and that he planned tariffs of 10% to 20% on all U.S. imports, with higher rates for China.

In his first four-year term in office, he imposed extra duties on EU steel and aluminium, which the subsequent administration of President Joe Biden suspended, but did not end.

EU trade chief Valdis Dombrovskis told a news conference after a meeting of EU ministers responsible for trade that it was too early to predict whether Trump would seek to address this.

He said there was broad agreement among EU ministers to maintain "constructive engagement" with the United States, not reopen old trade disputes, and avoid new ones.

"However, if we see certain new measures addressed against the European economy or European companies, we should be ready to react in a coordinated, precise and proportionate way," said Dombrovskis, who is set to be replaced as European trade commissioner by Slovak Maros Sefcovic next month.

An EU diplomat separately confirmed this stance of pushing a positive agenda while being ready with concrete countermeasures.

Trump imposed tariffs on 6.4 billion euros ($6.7 billion) of EU steel and aluminium in 2018. The EU responded with extra duties on 2.8 billion euros of U.S. goods, such as bourbon and Harley-Davidson motorcycles. The U.S. measures are currently suspended until the end of 2025.

The two sides also agreed a truce until mid-2026 on tariffs linked to their two-decade conflict over aircraft subsidies, 

($1 = 0.9492 euro)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BMO Previews AGF Management's Q2
BMO Previews AGF Management's Q2
Jun 20, 2024
01:38 PM EDT, 06/20/2024 (MT Newswires) -- AGF Management reports its second quarter results on June 26. BMO is looking for second quarter EBITDA of $35.3 million ($35.5 million consensus), and earnings per share of $0.34 (consensus $0.34). Analyst Tom MacKinnon expects net outflows of $50 million, reflecting the challenging environment in the mutual fund industry. After recently increasing our...
United Airlines Flight Reportedly Forced to Return to Departure Location After Engine Issues
United Airlines Flight Reportedly Forced to Return to Departure Location After Engine Issues
Jun 20, 2024
01:29 PM EDT, 06/20/2024 (MT Newswires) -- United Airlines (UAL) Flight 325 on Thursday had to return to Bradley Airport in Connecticut after a portion of the engine's sound-dampening outer liner fell on the runway and the aircraft experienced an issue with its engine, according to media reports. The plan was reportedly Airbus aircraft and was headed to Denver International...
Omai Gold Mines Raises About $13 Million Via Brokered Private Placement
Omai Gold Mines Raises About $13 Million Via Brokered Private Placement
Jun 20, 2024
01:31 PM EDT, 06/20/2024 (MT Newswires) -- Omai Gold Mines ( OMGGF ) on Thursday said it raised $13 million in a private placement of shares. The company said it placed 108.33-million shares priced at $0.12 in the financing. The company plans to use the proceeds for exploration and development, and general working capital purposes. Omai shares were last seen...
Gilead Sciences' Twice-Yearly Shot Prevents 100% of HIV Cases in Trial, Shares Jump
Gilead Sciences' Twice-Yearly Shot Prevents 100% of HIV Cases in Trial, Shares Jump
Jun 20, 2024
01:31 PM EDT, 06/20/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said Thursday its experimental twice-yearly Lenacapavir shot to prevent HIV was 100% effective in women in a late-stage trial, sending the drugmaker's shares soaring. The Purpose 1 phase 3 trial is assessing the safety and efficacy of Lenacapavir for pre-exposure prophylaxis, or PrEP, and once-daily oral Descovy in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved